https://www.selleckchem.com/pr....oducts/edralbrutinib
e to T2DM. Serum AKAP1 level decreases slightly in patients with T2DM and obesity. Subjects with lower leve1s of serum AKAP1 are susceptible to T2DM. Oxidative stress has been implicated in the pathogenesis of thyroid-associated orbitopathy (TAO) in patients with Graves' disease (GD). This study assessed the effect of thyroid hormone abnormalities on selected antioxidant parameters in patients with active TAO. The study group consisted of 56 patients with GD and active TAO treated with antithyroid medication. Depending on the thyr